Muhammad Shahab

发表

In silico designing of a multi-epitope vaccine against Burkholderia pseudomallei: reverse vaccinology and immunoinformatics

Chandni Hayat, S. Akter, Guojun Zheng, 2022, Journal of Genetic Engineering and Biotechnology.

Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2

K. Al-Zaydi, A. Salam, M. Almehmadi, 2022, Molecules.

Design of a novel multiple epitope-based vaccine: an immunoinformatics approach to combat monkeypox

Chandni Hayat, S. Khan, Zaheer Ul-Haq, 2022, Journal of biomolecular structure & dynamics.

Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients

Mohammad Samir Uzzaman, Chandni Hayat, S. Akter, 2022, Journal of Genetic Engineering and Biotechnology.

An Immunoinformatics Approach to Design Novel and Potent Multi-Epitope-Based Vaccine to Target Lumpy Skin Disease

Muneeba Aslam, M. Imran, M. Kamal, 2023, Biomedicines.

An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae

S. Akter, S. Islam, J. I. N. Oliveira, 2023, Journal of Genetic Engineering and Biotechnology.

Biocatalytic synthesis of chiral five-membered carbasugars intermediates utilizing CV2025 ω-transaminase from Chromobacterium violaceum.

Guojun Zheng, Muhammad Shahab, Chaoqun Liang, 2023, Journal of Bioscience and Bioengineering.

In Silico Identification of Lead Compounds for Pseudomonas Aeruginosa PqsA Enzyme: Computational Study to Block Biofilm Formation

M. Danial, T. Khan, Guojun Zheng, 2023, Biomedicines.

Design of a Novel and Potent Multi-Epitope Chimeric Vaccine against Human Papillomavirus (HPV): An Immunoinformatics Approach

Yening Zou, Guojun Zheng, Muhammad Shahab, 2023, Biomedicines.

Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site

M. Saki, S. Akter, M. Sarkar, 2023, Informatics in Medicine Unlocked.

Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy

F. Alasmari, Muhammad Shahab, A. Alasmari, 2023, Scientific reports.

Machine learning-based drug design for identification of thymidylate kinase inhibitors as a potential anti-Mycobacterium tuberculosis.

T. Khan, Guojun Zheng, Muhammad Shahab, 2023, Journal of Biomolecular Structure and Dynamics.

Machine Learning-Based Virtual Screening and Molecular Simulation Approaches Identified Novel Potential Inhibitors for Cancer Therapy.

Dongqing Wei, Abbas Khan, Guojun Zheng, 2023, Biomedicines.

Immunoinformatics and Reverse Vaccinology Driven Predication of a Multi-Epitope Vaccine Against Borrelia burgdorferi and Validation Through in silico Cloning and Immune Simulation.

Chandni Hayat, Haleema Bibi, Guojun Zheng, 2023, Current pharmaceutical design.

Immunoinformatics-based potential multi-peptide vaccine designing against Jamestown Canyon Virus (JCV) capable of eliciting cellular and humoral immune responses.

Dongqing Wei, Abdulrahman Alshammari, Abbas Saleem Khan, 2023, International journal of biological macromolecules.

In silico mutagenesis-based designing of oncogenic SHP2 peptide to inhibit cancer progression

S. Khan, Mohammed Bourhia, Yousef A. Bin Jardan, 2023, Scientific reports.

In silico Mutagenesis and Modeling of Decoy Peptides Targeting CIB1 to Obscure its Role in Triple-negative Breast Cancer Progression.

A. Wadood, Guojun Zheng, Muhammad Shahab, 2023, Current pharmaceutical design.

Strategies for targeting CIB1, a challenging drug target.

A. Wadood, Guojun Zheng, Muhammad Shahab, 2022, Current pharmaceutical design.

Spike protein mutations and structural insights of pangolin lineage B.1.1.25 with implications for viral pathogenicity and ACE2 binding affinity

Mohammad Samir Uzzaman, M. Farzana, M. A. Molla, 2023, Scientific reports.